NASDAQ: AUTLAutolus Therapeutics PLC Earnings Dates, Reports, Calls
Autolus Therapeutics earnings were -$289.0M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest AUTL earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$71.6M, down 20.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AUTL reported annual earnings of -$287.5M, with 30.3% growth.
AUTL earnings history
Current Revenue
$92.6M
Current Earnings
-$289.0M
Current Profit Margin
-312%
AUTL Return on Equity
Current Company
-128.6%
Current Industry
-142%
Current Market
13.5%
AUTL's Return on Equity (-128.6%)... subscribe to Premium to read more.
High Return on Equity Performance
AUTL Return on Assets
Current Company
-46.3%
Current Industry
-13.7%
AUTL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when AUTL announces earnings.
AUTL Return on Capital Employed
Current Company
-54.09%
Current Industry
-9.5%
AUTL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
AUTL vs Biotech Stocks
Autolus Therapeutics Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.